Rufinamide
NDC 67877-673, Rufinamide, suspension, from Ascend Laboratories, LLC.
- Product NDC
- 67877-673
- Status
- Listed
- Labeler
- Ascend Laboratories, LLC
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA213410
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67877-673 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RUFINAMIDE40 mg/mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67877-673-62 | 67877067362 | 1 BOTTLE in 1 CARTON (67877-673-62) / 460 mL in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/a02ca527-bd8f-49ef-89fa-91fac154bffeNADAC price for package 67877067362
GET /v1/drugs/nadac/67877067362
Use it
Look up 67877-673 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67877-673 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67877-673. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.